Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serum 2039125 03 vs Hydroquinone 4% in Facial Melasma
NCT06787846Completed
- Sponsor
- Cosmetique Active International
- Start
- Aug 2023
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms), sponsored by Cosmetique Active International. Primary endpoint: modified Melasma Area Severity Index at 3 months. Started Aug 2023; status: completed.
Beyond the preview
Go deeper on NCT06787846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06787846.